Immuron Ltd. Files 6-K Report for July 2024
Ticker: IMRN · Form: 6-K · Filed: Jul 5, 2024 · CIK: 1660046
| Field | Detail |
|---|---|
| Company | Immuron LTD (IMRN) |
| Form Type | 6-K |
| Filed Date | Jul 5, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulatory-filing, foreign-private-issuer
TL;DR
Immuron Ltd. filed a 6-K on July 5th, reporting a publication for July 2024. Standard disclosure.
AI Summary
On July 5, 2024, Immuron Ltd. filed a Form 6-K to report a publication. The filing indicates that the company is a foreign private issuer and is furnishing information to the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The report covers the month of July 2024 and includes one announcement published by the company.
Why It Matters
This filing provides an update on Immuron Ltd.'s regulatory disclosures, informing investors about published announcements relevant to the company's operations and compliance.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of a published announcement by a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Immuron Ltd (company) — Registrant
- July 5, 2024 (date) — Filing Date
- 001-38104 (company_id) — SEC File Number
FAQ
What type of report is Immuron Ltd. filing?
Immuron Ltd. is filing a Form 6-K, which is a Report of Foreign Private Issuer.
What is the filing date of this report?
The filing date of this report is July 5, 2024.
For what period is this report being filed?
This report is being filed for the month of July 2024.
Does Immuron Ltd. file annual reports under Form 20-F or 40-F?
Immuron Ltd. indicates it files annual reports under cover of Form 20-F.
What is the SEC file number for Immuron Ltd.?
The SEC file number for Immuron Ltd. is 001-38104.
Filing Stats: 316 words · 1 min read · ~1 pages · Grade level 18.7 · Accepted 2024-07-05 06:27:24
Filing Documents
- ea0208991-6k_immuron.htm (6-K) — 13KB
- ea020899101ex99-1_immuron.htm (EX-99.1) — 22KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- ex99-1_002.jpg (GRAPHIC) — 7KB
- ex99-1_003.jpg (GRAPHIC) — 3KB
- 0001213900-24-059244.txt ( ) — 57KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of July 2024 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on July 4, 2024 titled: - “Immuron CEO Steven Lydeamore to present at Sharewise” A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Immuron CEO Steven Lydeamore to present at Sharewise 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: July 5, 2024 By: /s/ Phillip Hains Phillip Hains Company Secretary 3